About Metactive Medical
Metactive Medical is a company based in Olathe (United States) founded in 2011. Metactive Medical has raised $4.7 million across 5 funding rounds from investors including NIH, Mid America Angels and Serra Ventures. The company has 31 employees as of December 31, 2021. Metactive Medical operates in a competitive market with competitors including Rapid Medical, CoAxia, Cerus Endovascular, Anaconda Biomed and Oxford Endovascular, among others.
- Headquarter Olathe, United States
- Employees 31 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Artio Medical, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.7 M (USD)
in 5 rounds
-
Latest Funding Round
$1.2 M (USD), Series A
Mar 08, 2018
-
Investors
NIH
& 4 more
-
Employee Count
31
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Metactive Medical
Metactive Medical has successfully raised a total of $4.7M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $1.2 million completed in March 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Metactive Medical
Metactive Medical has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, Mid America Angels and Serra Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Angel investments are facilitated for US-based startups by Mid-America Angels.
|
Locked | Locked | Locked | |
|
Venture capital fund focused on Agtech and multiple sectors
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Metactive Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Metactive Medical
Investment portfolio details for Metactive Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Metactive Medical
Detailed financials for Metactive Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Metactive Medical Comparisons
Peer comparison for Metactive Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Metactive Medical
Metactive Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rapid Medical, CoAxia, Cerus Endovascular, Anaconda Biomed and Oxford Endovascular, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Neurovascular interventional devices including distal access catheters are developed.
|
|
| Locked | Locked | Locked |
Catheter-based treatment for cerebral ischemia
|
|
| Locked | Locked | Locked |
Interventional neuroradiology devices are developed for minimally invasive aneurysm treatment.
|
|
| Locked | Locked | Locked |
Medical devices for mechanical thromboectomy and clot removal are developed.
|
|
| Locked | Locked | Locked |
Metallic mesh devices for brain aneurysms are developed.
|
|
| Locked | Locked | Locked |
A hybrid polymer-metal stent for brain aneurysms is developed.
|
Detailed competitors of Metactive Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Metactive Medical
Complete news archive for Metactive Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Metactive Medical
Metactive Medical was founded in 2011 and raised its 1st funding round 4 years after it was founded.
Metactive Medical is headquartered in Olathe, United States. It is registered at Olathe, Kansas, United States.
Metactive Medical is a funded company, having raised a total of $4.7M across 5 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Metactive Medical is 31.
Metactive Medical was founded in 2011 and is based in Olathe, United States. Endovascular devices are developed for addressing peripheral and neurovascular diseases within the medical technology sector. The initial product is engineered to facilitate occlusion and sealing of cerebral aneurysms along with other vessel segments, utilizing an over-the-wire microcatheter platform. Operations emphasize innovation in vascular interventions for clinical applications.
Metactive Medical's top competitors include Rapid Medical, Fluid Biomed and Anaconda Biomed.
Metactive Medical has 5 investors. Key investors include NIH, Mid America Angels, Serra Ventures, National Heart, Lung, and Blood Institute, and Kansas Bioscience Authority.